{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:16:59Z","timestamp":1791231419753,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10147-025-02730-4","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:03:50Z","timestamp":1744016630000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-5190","authenticated-orcid":false,"given":"Manabu","family":"Seino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Gonai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2730_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1200\/PO.19.00406","volume":"4","author":"EA Williams","year":"2020","unstructured":"Williams EA, Werth AJ, Sharaf R et al (2020) Vulvar squamous cell carcinoma: comprehensive genomic profiling of HPV+ versus HPV- forms reveals distinct sets of potentially actionable molecular targets. JCO precis Oncol 4:647\u2013661","journal-title":"JCO precis Oncol"},{"issue":"12","key":"2730_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.883805","volume":"18","author":"SK Baral","year":"2022","unstructured":"Baral SK, Biswas P, Kaium MA et al (2022) A comprehensive discussion in vaginal cancer based on mechanisms, treatments, risk factors and prevention. Front Oncol 18(12):883805","journal-title":"Front Oncol"},{"key":"2730_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","volume":"22","author":"N Abu-Rustum","year":"2024","unstructured":"Abu-Rustum N, Yashar CM, Arend R et al (2024) Vulvar cancer, version 3. J Natl Compr Canc Netw 22:117\u2013135","journal-title":"J Natl Compr Canc Netw"},{"key":"2730_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/cas.14754","volume":"112","author":"Y Mukai","year":"2021","unstructured":"Mukai Y, Ueno H (2021) Establishment and implementation of cancer genomic medicine in Japan. Cancer Sci 112:970\u2013977","journal-title":"Cancer Sci"},{"key":"2730_CR5","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.CD-22-0417","volume":"12","author":"T Kohno","year":"2022","unstructured":"Kohno T, Kato M, Kohsaka S et al (2022) C-CAT: the national datacenter for cancer genomic medicine in Japan. Cancer Discov 12:2509\u20132515","journal-title":"Cancer Discov"},{"key":"2730_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein RM, Lee CH, Shoushtari AN et al (2019) Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51:202\u2013206","journal-title":"Nat Genet"},{"key":"2730_CR7","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM et al (2017) Tumor mutational burden and response rate to PD-1 inhibition. NEJM 377:2500\u20132501","journal-title":"NEJM"},{"key":"2730_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126908","author":"M Yarchoan","year":"2019","unstructured":"Yarchoan M, Albacker LA, Hopkins AC et al (2019) PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.126908","journal-title":"JCI Insight"},{"key":"2730_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40425-019-0647-4","volume":"7","author":"L Fancello","year":"2019","unstructured":"Fancello L, Gandini S, Pelicci PG et al (2019) Tumor mutational burden quantification from targeted gene panels: major advancements and challenges. J Immunother Cancer 7:183","journal-title":"J Immunother Cancer"},{"key":"2730_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2220\/biomedres.39.159","volume":"39","author":"K Hatakeyama","year":"2018","unstructured":"Hatakeyama K, Nagashima T, Urakami K et al (2018) Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing. Biomedical Res 39:159\u2013167","journal-title":"Biomedical Res"},{"key":"2730_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E et al (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol 30:44\u201356","journal-title":"Ann Oncol"},{"key":"2730_CR12","unstructured":"https:\/\/for-patients.c-cat.ncc.go.jp\/registration_status\/ Accessed 14 Sep"},{"key":"2730_CR13","unstructured":"WHO Classification of Tumours of Female Reproductive Organs (2014) WHO Classification of Tumours. 4th Edition"},{"key":"2730_CR14","doi-asserted-by":"publisher","first-page":"13058","DOI":"10.1038\/s41598-024-63913-z","volume":"14","author":"E Fujii","year":"2024","unstructured":"Fujii E, Kobayashi Kato M, Yamaguchi M et al (2024) Genomic profiles of Japanese patients with vulvar squamous cell carcinoma. Sci Rep 14:13058","journal-title":"Sci Rep"},{"key":"2730_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Fakih M, Lopez J et al (2020) Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol 21:1353\u20131365","journal-title":"Lancet Oncol"},{"key":"2730_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EV Allen","year":"2015","unstructured":"Allen EV, Miao D, Schilling B et al (2015) Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350:207\u2013211","journal-title":"Science"},{"key":"2730_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12885-021-07978-3","volume":"21","author":"Y Ge","year":"2021","unstructured":"Ge Y, Wei F, Du G et al (2021) The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity. BMC Cancer 21:240","journal-title":"BMC Cancer"},{"key":"2730_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cca.2018.07.014","volume":"486","author":"Z Wang","year":"2018","unstructured":"Wang Z, Peng S, Guo L et al (2018) Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma. Clin Chim Acta 486:9\u201317","journal-title":"Clin Chim Acta"},{"key":"2730_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ctrv.2018.12.005","volume":"73","author":"FL Boer","year":"2019","unstructured":"Boer FL, Eikelder M, Kapiteijn E et al (2019) Vulvar malignant melanoma: pathogenesis, clinical behaviour and management: review of the literature. Cancer Treat Rev 73:91\u2013103","journal-title":"Cancer Treat Rev"},{"key":"2730_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/CMR.0000000000000894","volume":"33","author":"D Ogata","year":"2023","unstructured":"Ogata D, Nishio S, Hatta N et al (2023) Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan. Melanoma Res 33:300\u2013308","journal-title":"Melanoma Res"},{"key":"2730_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2018.04.562","volume":"150","author":"A Gadducci","year":"2018","unstructured":"Gadducci A, Carinelli S, Guerrieri ME et al (2018) Melanoma of the lower genital tract: prognostic factors and treatment modalities. Gynecol Oncol 150:180\u2013189","journal-title":"Gynecol Oncol"},{"key":"2730_CR22","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/ijc.28625","volume":"134","author":"KD Bishop","year":"2014","unstructured":"Bishop KD, Olszewski AJ (2014) Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer 134:2961\u20132971","journal-title":"Int J Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02730-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:04:24Z","timestamp":1745301864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02730-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2730"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02730-4","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}